United States · FDA National Drug Code directory
ZIOPTAN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82584-609_50281dbf-7a22-69dc-e063-6294a90a2cb9
- Product NDC
- 82584-609
- Form
- SOLUTION/ DROPS
- Composition / generic term
- Tafluprost
- Labeler
- Thea Pharma Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20221028
- Source listing expiry
- 20271231
Source-listed ingredients
- TAFLUPROST — .015 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 3 POUCH in 1 CARTON (82584-609-30) / 10 VIAL, SINGLE-USE in 1 POUCH (82584-609-01) / .3 mL in 1 VIAL, SINGLE-USE · 82584-609-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →